Release date : 2019/7/21 10:29:38
From 2007 to 2010, the global medical device market has an average annual growth rate of sales of more than 12%. In the same period, the global pharmaceutical market sales annual growth rate is about 5%.
In 2006, the global medical device market sales were only 43% of the pharmaceutical market sales; in 2010, the two major market sales ratios were close to 1:1. In the past five years, the global medical device market has undergone some important changes: First, The growth rate of the medical device market is significantly higher than that of the pharmaceutical market; secondly, the situation dominated by the oligarchs in the medical device market is becoming more and more obvious; third, the combination of medical devices and drugs is more closely; and fourth, the promotion of digital technology in medical devices The application has developed rapidly.
Instruments and medicines are "evenly divided"
According to foreign statistics, in 2007, the global medical device market sales exceeded 300 billion US dollars; in 2008 it was 336 billion US dollars; in 2010 this figure rose to 298 billion US dollars. In the past four years, the global medical device market sales annual growth rate reached 12% to 13%; while the global pharmaceutical market sales growth rate was only around 5%. In 2006, the global medical device market sales were equivalent to 43% of the pharmaceutical market sales; in 2010, the two major market sales were almost "flat." Oligarchic leadership is becoming more apparent
Different from the situation of “multiple, small and scattered” in China's medical device industry, the medical device industry in developed countries has formed an obvious “oligarchic rule”, and the global medical device market has also shown a similar pattern.
According to the statistics of the European Medical Device Industry Association, the sales of 25 medical device companies (70% of which are US-based companies) account for more than 60% of the total sales of the global medical device market. The 25 medical device companies are sorted by sales order: 1. Johnson & Johnson; 2. General Medical; 3. Siemens; 4. Medtronic; 5. Baxter; 6. Covidien; 7. Philips; 8. Boston Scientific; 9. Roche 10.Box; 11. Albert; 12. Stryker; 13. Cardinal Health; 14. Olympus; 15. 3M; 16. Zimmer Holdings Company; 17. St.Jude; 18.SNN; 19. Beckman; 20. Synthes; 21. Terumo; 22. Fresenius; 23. Alcon; 24. Carestream; 25. CR Bard .
The company's main products cover cardiovascular disease treatment devices (such as vascular stents, pacemakers, etc.), imaging diagnostic equipment, orthopedics and orthopedic devices, surgical instruments, in vitro diagnostic products and sanitary materials.
Digital technology applications are unstoppable
In recent years, the promotion and application of digital technology in medical device products has been extremely rapid. Some researchers use Bluetooth technology to transform existing medical devices and upgrade them into smart products.
For example, using Bluetooth technology as a platform, researchers have developed portable digital data that can transmit various vital vital signs such as patient's breathing, pulse, blood pressure, oxygen saturation, and glycemic index to a doctor's computer terminal through a dedicated mobile phone. Monitoring system. This kind of monitoring system is like a “mobile hospital”, which changes the traditional medical model, so that the doctor can keep abreast of the patient's condition changes “without leaving the hospital”, and the patient also saves the trouble of going to the hospital for examination, and this A system also provides a premise for a "family bed" disease management model. At present, similar new portable digital monitors based on Bluetooth technology have been listed in developed countries such as the United States.
US medical device manufacturers have also introduced an "intelligent insulin pump" by combining an implantable insulin pump with an automatic blood glucose analysis sensor. The medical device can determine whether it is necessary to turn on the insulin pump and calculate the infusion dose according to the patient's blood sugar condition, thereby avoiding the occurrence of hypoglycemia and other critical situations in the diabetic patient, and making the treatment more timely and reasonable. The implanted insulin pump that was previously marketed can only deliver the therapeutic drug constantly at a speed set by the doctor. Experts believe that the most important technology in smart medical devices is embedded software. In the future, the "destiny" of many medical device products in the market will depend on the performance of their medical software. Software medical device products such as electronic medical records based on digital technologies such as Bluetooth are expected to completely change the existing medical model.
The pharmaceutical-mechanical combination market will accelerate
Another mainstream trend in medical device products is the growing links between medical devices and drugs. In the last century, medical devices and drugs were basically "all the way."
According to the statistics of the European Medical Device Industry Association, at present, the most popular pharmaceutical-mechanical combination products in the global medical device market are: 1. Pre-filled syringes, that is, pre-filled with a certain amount of liquid medicine (such as insulin, life) Long hormones, vaccines, etc., because the prefilled syringe is extremely convenient to use, it is very popular with medical staff; 2. Drug-eluting vascular stent; 3. Implantable insulin pump; 4. Implantable long-acting sustained-release intrauterine IUDs (with estrogens); 5. Implantable orthopedic materials, such as artificial bone joints and bone cement containing osteoblast growth factor; 6. Implantable nanodevices containing bioengineered products such as stem cells, etc. .
Experts predict that in the next few years, the pharmaceutical-mechanical combination will become a very important product category in the global medical device industry, with an average annual growth rate of more than 20%.
Actively respond to transformation and upgrading
At present, China's medical device market sales are only 11% to 12% of China's pharmaceutical market, and the market still has a lot of room for development. However, China's new medical devices are far from the developed countries. Moreover, 80% of medical device manufacturers in China are small enterprises with annual sales of only several million yuan. Most of the products have low added value (such as disposable infusion). , sanitary materials, medical catheters, general surgical instruments, etc.). Although these labor-intensive products are currently selling well, their profit margins will gradually shrink, and the pressure of homogenization competition from Southeast Asian countries such as Vietnam and Thailand is increasing. Therefore, in the fierce market competition, China's medical device companies are likely to face a big reshuffle situation. To this end, China's medical device industry should conform to the development trend of the global medical device market, rationally change the production pattern as soon as possible, aim at the new direction of product development, and realize the transformation and upgrading of the industry.